Long-term evolution and determinants of renal function in HIV-infected patients who began receiving combination antiretroviral therapy in 1997-1999, ANRS CO8 APROCO-COPILOTE

Clinical Infectious Diseases

Volumn 49, Issue 12, 2009, Pages 1950-1954

  Leport, Catherine ^a   Bouteloup, Vincent ^c   Rossert, Jérôme ^a   Garré, Michel ^d   Lordache, Laura ^a   Dellamonica, Pierre ^e   Herson, Serge ^b   Raffi, François ^f   Chêne, Geneviève ^c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BODY MASS; CAUCASIAN; DRUG EXPOSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KIDNEY; MALE; MIDDLE AGED;

EID: 72049109940     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/648445     Document Type: Article

References (24)

1. Gardner LI, Holmberg SD, Williamson JM, et al. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr 2003; 32:203-209
2. Szczech LA, Hoover DR, Feldman JG, et al. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 2004; 39:1199-1206
3. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:1559-1585
4. Izzedine H, Deray G. The nephrologist in the HAART era. AIDS 2007; 21:409-421
5. Krawczyk CS, Holmberg SD, Moorman AC, Gardner LI, McGwin G Jr. Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS 2004; 18:2171-2178 (Pubitemid 39463682)
6. Roling J, Schmid H, Fischereder M, Draenert R, Goebel FD. HIVassociated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 2006; 42:1488-1495
7. Kalayjian RC, Franceschini N, Gupta SK, et al. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 2008; 22: 481-487 (Pubitemid 351317289)
8. Reid A, Stohr W, Walker AS, et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis 2008; 46:1271-1281 (Pubitemid 351589914)
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470 (Pubitemid 29135798)
10. van Deventer HE, George JA, Paiker JE, Becker PJ, Katz IJ. Estimating glomerular filtration rate in black South Africans by use of the modification of diet in renal disease and Cockcroft-Gault equations. Clin Chem 2008; 54:1197-1202
11. Mocroft A, Kirk O, Gatell J, et al. Chronic renal failure among HIV1-infected patients. AIDS 2007; 21:1119-1127 (Pubitemid 46763282)
12. Betjes MG, Verhagen DW. Stable improvement of renal function after initiation of highly active anti-retroviral therapy in patients with HIV1-associated nephropathy. Nephrol Dial Transplant 2002; 17:1836-1839
13. Szczech LA, Edwards LJ, Sanders LL, et al. Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol 2002; 57:336-341
14. Szczech LA, Gange SJ, van der Horst C, et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int 2002; 61:195-202.
15. Tashima KT, Horowitz JD, Rosen S. Indinavir nephropathy. N Engl J Med 1997; 336:138-140
16. Vigano A, Rombola G, Barbiano di Belgioioso G, Sala N, Prindpi N. Subtle occurrence of indinavir-induced acute renal insufficiency. AIDS 1998; 12:954-955 (Pubitemid 28241412)
17. Boubaker K, Sudre P, Bally F, Vogel G, Meuwly JY, Glauser MP, et al. Changes in renal function associated with indinavir. AIDS 1998; 12: F249-54. (Pubitemid 28558592)
18. Boyd MA, Siangphoe U, Ruxrungtham K, et al. The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity. J Antimicrob Chemother 2006; 57: 1161-1167 (Pubitemid 44644420)
19. Fux CA, Simcock M, Wolbers M, et al. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antivir Ther 2007; 12:1165-1173
20. Gayet-Ageron A, Ananworanich J, Jupimai T, et al. No change in calculated creatinine clearance after tenofovir initiation among Thai patients. J Antimicrob Chemother 2007; 59:1034-1037 (Pubitemid 47073382)
21. Jones R, Stebbing J, Nelson M, et al. Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study. J Acquir Immune Defic Syndr 2004; 37:1489-1495 (Pubitemid 39602339)
22. Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis 2008; 47:1449-1457
23. Gallant JE, Parish MA, Keruly JC, Moore RD. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clin Infect Dis 2005; 40:1194-1198
24. Estrella M, Fine DM, Gallant JE, et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clin Infect Dis 2006; 43:377-380 (Pubitemid 44078912)